Nucleic Acid Therapeutics Impact Factor in Chemistry Journals

Nucleic Acid Therapeutics in Chemistry Journals

Journal Country: United States
Journal Q tier: Q1
Publishing Firm: Mary Ann Liebert Inc.
History: 2011-2022
Journal Homepage: Not Available
Journal ISSN: 21593345, 21593337

Research Categories

Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)

Impact Score: 3.95
h-Index: 73
SJR: 1.49
Ranking: 2164

About Nucleic Acid Therapeutics

Nucleic Acid Therapeutics is a journal covering the technologies/fields/categories related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Mary Ann Liebert Inc.. The overall rank of Nucleic Acid Therapeutics is 2164.According to SCImago Journal Rank (SJR), this journal is ranked 1.490. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 73. The best quartile for this journal is Q1.The ISSN of Nucleic Acid Therapeutics journal is 21593345, 21593337.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nucleic Acid Therapeutics is cited by a total of 472 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.